Delivery Order SPE2DB24D2013-SPE2DB25FCJYE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,440.44 to AmerisourceBergen Drug Corp for AREXVY vial kits on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,168.96 delivery order for AREXVY vial kits under contract 4568853131 on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement to support federal medical supply requirements. The contract will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for AREXVY vial kits, with a ceiling value of $1,440.44. This firm fixed-price delivery order, awarded on July 30, 2025, represents a competitively awarded contract with no set-aside designation and is scheduled for ultimate completion by July 31, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,693.65 contract is for the delivery of AREXVY VIAL KITS and has an ultimate completion date of June 11, 2025. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $66,924.03 firm fixed price delivery order to Amerisourcebergen Drug Corp for 4565536193 AREXVY VIAL KITS. This order was placed under an Indefinite Delivery Contract (IDC) with Amerisourcebergen valued at up to $999,999,999 through December 2025 for delivering a range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation, and the work is to be...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,760.32 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of AREXVY VIAL KITS. This award does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025 to deliver a comprehensive range of...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $43,377.81 to AmerisourceBergen Drug Corp on August 18, 2025, with completion expected by August 19, 2025. This firm fixed-price, competitively awarded delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026. The delivery order represents a child contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,302.51 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The delivery order will be fulfilled from the vendor's...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $111,086.64 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitive award, which carries no set-aside designation, is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $82,029.40 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCJYEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,936.01 to AmerisourceBergen Drug Corp for AREXVY vial kits on August 19, 2025, with completion expected by August 20, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. The contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's delivery order portfolio with the Defense Logistics Agency encompasses a comprehensive range of pharmaceutical products and medical supplies spanning multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This specific delivery order for AREXVY vial kits supports the DLA's mission to supply critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 8/19/25 |